| scholarly article | Q13442814 |
| P356 | DOI | 10.1023/A:1018899802836 |
| P50 | author | Hubert Girault | Q28800903 |
| Bernard Testa | Q96013808 | ||
| P2093 | author name string | Frédéric Reymond | |
| Didier Morin | |||
| Guillaume Steyaert | |||
| Jean‐Paul Tillement | |||
| Pierre‐Alain Carrupt | |||
| P433 | issue | 5 | |
| P304 | page(s) | 616-624 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P478 | volume | 16 |
| Q43873826 | Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine |
| Q34264465 | Mitochondria as target for antiischemic drugs |
| Q38006826 | New strategies to optimize kidney recovery and preservation in transplantation |
| Q43990747 | Recognition forces involved in mitochondrial binding to a low-affinity trimetazidine binding site related to anti-ischemic activity |
| Q53569359 | Trimetazidine inhibits cardiomyocyte apoptosis in a rabbit model of ischemia-reperfusion. |
| Q41976491 | [(3)H]-trimetazidine mitochondrial binding sites: regulation by cations, effect of trimetazidine derivatives and other agents and interaction with an endogenous substance |
Search more.